Medicinal mushroom Lingzhi or Reishi, Ganoderma lucidum (W.Curt.:Fr.) P. Karst., β-glucan induces toll-like receptors and fails to induce inflammatory cytokines in NF-κB inhibitor-Treated macrophages

International Journal of Medicinal Mushrooms

Volumn 13, Issue 3, 2011, Pages 213-225

  Batbayar, Sainkhuu ^a   Kim, Mi Jeong ^a   Kim, Ha Won ^a  

^a University of Seoul   (South Korea)

Author keywords

Cytokine; Dectin 1; Ganoderma lucidum; Glucan; Lingzhi or Reishi mushroom; Medicinal mushrooms; NF B; Toll like receptor

Indexed keywords

ANTIBODY; BETA GLUCAN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 9; RANTES; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL LINE; CELL SECRETION; CONCENTRATION RESPONSE; CYTOKINE RELEASE; DRUG RECEPTOR BINDING; FLOW CYTOMETRY; GANODERMA LUCIDUM; GRANULOCYTE; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INFLAMMATION; MACROPHAGE; MOUSE; MUSHROOM; NONHUMAN; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECIES; T LYMPHOCYTE;

ANIMALS; BETA-GLUCANS; CELL LINE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; I-KAPPA B PROTEINS; INTERLEUKIN-1; INTERLEUKIN-6; LECTINS, C-TYPE; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REACTIVE OXYGEN SPECIES; REISHI; RNA; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; ZYMOSAN;

BASIDIOMYCOTA; GANODERMA LUCIDUM;

EID: 79960068491     PISSN: 15219437     EISSN: 19404344     Source Type: Journal    
DOI: 10.1615/IntJMedMushr.v13.i3.10     Document Type: Article

References (40)

1. Wasser SP, Weis AL. Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspectives (Review). Int J Med Mushrooms. 1999;1:31-62.
2. Goldman R. Characteristics of the beta-glucan receptor of murine macrophages. Exp Cell Res. 1988;174(2):481-90.
3. de Jong MA, Vriend LE, Theelen B, Taylor ME, Fluitsma D, Boekhout T, Geijtenbeek TB. C-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi. Mol Immunol. 2010;47(6):1216-25.
4. van Bruggen R, Drewniak A, Jansen M, van Houdt M, Roos D, Chapel H, Verhoeven AJ, Kuijpers TW. Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for beta-glucan-bearing particles. Mol Immunol. 2009;47(2-3):575-81.
5. Taylor PR, Brown GD, Reid DM, Willment JA, Martinez-Pomares L, Gordon S, Wong SYC. The β-Glucan receptor, Dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol. 2002;169:3867-82.
6. Willment JA, Marshall AS, Reid DM, Williams DL, Wong SY, Gordon S, Brown GD. The human beta-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. Eur J Immunol. 2005;35(5):1539-47.
7. Ariizumi K, Shen GL, Shikano S, Xu, S, Ritter IIIR, Kumamoto T, Edelbaum D, Morita A, Gergstresser PR, Takashima A. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J Biol Chem. 2000;275:20157-67.
8. Brown GD, Gordon S. Immune recognition: a new receptor for beta-glucans. Nature. 2001;413:36-37.
9. Figdor CG, van Kooyk Y, Gosse J. Adema C-type lectin receptors on dendritic cells and Langerhans cells. Nature Rev Immunol. 2002;2(2):77-84.
10. Sung SK, Kim MJ, Lee DH, Choung SY, Kim BK, Kim HW. β-Glucan of Ganoderma Lucium Lloyd cooperatively induces tumor necrosis factor-α and Interleukin-6 with lipopolysaccharide by binding to Dectin-1. Int J Med Mushrooms. 2005; 7:193-200.
11. Brown J, O'Callaghan CA, Marshall AS, Gilbert RJ, Siebold C, Gordon S, Brown GD, Jones EY. Structure of the fungal beta-glucan-binding immune receptor dectin-1: implications for function. Protein Sci. 2007;16(6):1042-52.
12. Underhill DM. Toll-like receptors: networking for success. Eur J Immunol. 2003;33:1767-75.
13. Roeder A, Kirschning CJ, Rupec RA, Schaller M, Weindl G, Korting HC. Toll-like receptors as key mediators in innate antifungal immunity. Med Mycol. 2004;42:485-98.
14. Gantner BN, Simmons RM, Canavera SJ, Akira A, Underhill DM. Collaborative induction of inflammatory responses by dectin-1 and TLR2. J Exp Med. 2003;197:1107-19.
15. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez-Pomares L, Wong SY, Gordon S. Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med. 2002;196:407-12.
16. Karin M, Greten FR. NF-κB: Linking inflammation and immunity to cancer development and progression. Nature Rev Immunol. 2005;5:749-59.
17. Ishibashi K, Miura NN, Adachi Y, Ogura N, Tamura H, Tanaka S, Ohno N. DNA array analysis of altered gene expression in human leukocytes stimulated with soluble and particulate forms of Candida cell wall beta-glucan. Int Immunopharm. 2004;4:387-401.
18. Pugh CR, Fleshner M, Watkins LR, Maier SF, Rudy JW. The immune system and memory consolidation: a role for the cytokine IL-1β. Neurosci Biobehav Rev. 2001;25:29-41.
19. Toki H, Matsutomo S, Okabe K, Shimokawa T. Remission in hypoplastic acute myeloid leukaemia induced by granulocyte colony-stimulating factor. Lancet. 1989;1:1389-90.
20. Pelizzari AM, Drera M, D'Adda M, Ungari M, Marocolo D, Facchetti F, Bellotti D, Barlati S, Rossi G. Recombinant granulocyte-colony stimulating factor as treatment for poor prognosis oligoblastic acute myeloid leukemia in elderly patients. Haematol. 2007;92:106-9.
21. Benz R, Goede JS, Parlier V, Mühlematter D, Jotterand M, Fehr J. G-CSF-induced remission in two cases of acute myeloid leukemia. Leuk Res. 2008;32(7):1148-52.
22. Appay V, Rowland-Jones SL. RANTES: a versatile and controversial chemokine. Trends Immunol. 2001;22:83-87.
23. Villalta F, Zhang Y, Bibb KE, Kappes JC, Lima MF. The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide. Inf Immunity. 1998;66(10):4690-95.
24. Hornebeck W, Lambert E, Petitfrère E, Bernard P. Beneficial and detrimental influences of tissue inhibitor of metalloproteinase-1 (TIMP-1) in tumor progression. Biochim. 2005;87(3-4):377-83.
25. Ikenaka YH, Yoshiji S, Kuriyama J, Yoshii R, Noguchi H, Tsujinoue K, Yanase T, Namisaki H, Imazu T, Mazaki H, Fukui. Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model. Int J Cancer. 2003;105:340-46.
26. Brightbill HD, Libraty DH, Krutzik SR, Yang RB, Belisle JT, Bleharski JR, Maitland M, Norgard MV, Plevy SE, Smale ST, Brennan PJ, Bloom BR, Godowski PJ, Modlin RL. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Sci. 1999;285:732-36.
27. Nameda S, Saito M, Miura NN, Adachi Y, Ohno N. Effect of nitiric oxide of β-glucan/indomethacin-induced septic shock. Biol Pharm Bull. 2005;28:1254-58.
28. Byeon SE, Yoo DS, Lee J, Kim S, Rhee MH, Park HJ, Cho JY. Extracelluar signal-regulated kinase-dependent nitric oxide production from macrophage-like cells by lactic acid bacteria. Biomol Therapeutics. 2009;17(3):276-81.
29. Kumar S, Jyoti A, Keshari RS, Singh M, Barthwal MK, Dikshit M. Functional and molecular characterization of NOS isoforms in rat neutrophil precursor cells. Cytometry A. 2010;77(5):467-77.
30. Kuemmerle JF. Synergistic regulation of NOS II expression by IL-1β and TNF-α in cultured rat colonics smooth muscle cells. Am J Physiol. 1998;274:178-85.
31. Chen JY, Chiu JH, Chen HL, Chen TW, Yang WC, Yang AH. Human peritoneal mesothelial cells produce nitric oxide: induction by cytokines. Peritoneal Dialysis Int. 2000;20:772-77.
32. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci. 2004;75:639-53.
33. Hawn TR, Underhill DM. Toll-like receptors in innate immunity. In: Lotze MT, Thomson AW, editors. Measuring immunity: basic biology and clinical assessment. London: Elsevier Academic Press; 2005. pp. 80-89.
34. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol. 2001;31:3388-93.
35. Arika S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Let. 2003;85:85-95.
36. Yang RB, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature. 1998;395:284-88.
37. Tobe M, Isobe Y, Tomizawa H, Nagasaki T, Takahashi H, Hayashi H. A novel structural class of potent inhibitors of NF-κB activation: structure-activity relationships and biological effects of 6-aminoquinazoline derivatives. Bioorg Med Chem. 2003;11:3869-78.
38. Tsukada C, Yokoyama H, Miyaji C, Ishimoto Y, Kawamura H, Abo T. Immunopotentiation of intraepithelial lymphocytes in the intestine by oral administrations of β-glucan. Cell Immunol. 2003;221:1-5.
39. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Inf Immunity. 2000;68:7010-17.
40. Miettinen M, Sareneva T, Julkumen I, Matikainen S. IFNs activate Toll-like receptor gene expression in viral infections. Genes Immunity. 2001;2: 349-55.